U.S. Markets closed

DarioHealth Corp. (DRIO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
16.78+1.01 (+6.40%)
At close: 4:00PM EDT

16.75 -0.03 (-0.18%)
After hours: 4:00PM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close16.60
Open16.40
Bid16.80 x 800
Ask16.84 x 1400
Day's Range16.25 - 17.30
52 Week Range0.20 - 22.49
Volume63,234
Avg. Volume261,998
Market Cap127.375M
Beta (5Y Monthly)1.17
PE Ratio (TTM)N/A
EPS (TTM)-8.48
Earnings DateAug 12, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.10
  • DRIO: DarioHealth and HMC HealthWorks Announce Partnership Agreement
    Zacks Small Cap Research

    DRIO: DarioHealth and HMC HealthWorks Announce Partnership Agreement

    By John Vandermosten, CFA NASDAQ:DRIO READ THE FULL DRIO RESEARCH REPORT DarioHealth (NASDAQ:DRIO) and HMC HealthWorks announced that they had entered into a sales and distribution partnership. HMC will incorporate DarioHealth’s digital therapeutics (DTx) platform into its comprehensive care management programs and offer DarioHealth’s platform as a stand-alone option. HMC HealthWorks is a

  • DarioHealth and HMC HealthWorks Announce Partnership Agreement
    PR Newswire

    DarioHealth and HMC HealthWorks Announce Partnership Agreement

    DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, and HMC HealthWorks, a 40-year veteran in healthcare management with clinically-integrated models of care that reduce healthcare costs and improve population health, today announced that the companies have entered into a sales and distribution partnership pursuant to which HMC will incorporate DarioHealth's digital therapeutics solution into its comprehensive care management programs. HMC will offer DarioHealth's platform on both a stand-alone basis as well as incorporated into HMC's comprehensive care management solutions.

  • DarioHealth Appoints Eric Milledge as Chairman of its Newly Established Scientific Advisory Board
    PR Newswire

    DarioHealth Appoints Eric Milledge as Chairman of its Newly Established Scientific Advisory Board

    DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announces that Eric Milledge has joined DarioHealth as Chairman of the company's newly-established Scientific Advisory Board (SAB).